- Home
- BEATW vs GMAB Comparison
BEATW vs GMAB Comparison
Compare BEATW & GMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEATW
- GMAB
- Stock Information
- Founded
- BEATW 2015
- GMAB 1999
- Country
- BEATW United States
- GMAB Denmark
- Employees
- BEATW 20
- GMAB N/A
- Industry
- BEATW Retail: Computer Software & Peripheral Equipment
- GMAB Biotechnology: Pharmaceutical Preparations
- Sector
- BEATW Technology
- GMAB Health Care
- Exchange
- BEATW Nasdaq
- GMAB Nasdaq
- Market Cap
- BEATW N/A
- GMAB N/A
- IPO Year
- BEATW N/A
- GMAB N/A
- Fundamental
- Price
- BEATW $0.51
- GMAB $18.82
- Analyst Decision
- BEATW
- GMAB Buy
- Analyst Count
- BEATW 0
- GMAB 10
- Target Price
- BEATW N/A
- GMAB $40.00
- AVG Volume (30 Days)
- BEATW 4.7K
- GMAB 1.6M
- Earning Date
- BEATW 03-14-2025
- GMAB 05-01-2025
- Dividend Yield
- BEATW N/A
- GMAB N/A
- EPS Growth
- BEATW N/A
- GMAB 83.82
- EPS
- BEATW N/A
- GMAB 16.85
- Revenue
- BEATW N/A
- GMAB $2,988,286,182.00
- Revenue This Year
- BEATW N/A
- GMAB $19.81
- Revenue Next Year
- BEATW N/A
- GMAB $13.94
- P/E Ratio
- BEATW N/A
- GMAB $1.11
- Revenue Growth
- BEATW N/A
- GMAB 30.67
- 52 Week Low
- BEATW $0.50
- GMAB $18.48
- 52 Week High
- BEATW $0.62
- GMAB $30.50
- Technical
- Relative Strength Index (RSI)
- BEATW N/A
- GMAB 36.78
- Support Level
- BEATW N/A
- GMAB $18.99
- Resistance Level
- BEATW N/A
- GMAB $20.37
- Average True Range (ATR)
- BEATW 0.00
- GMAB 0.42
- MACD
- BEATW 0.00
- GMAB -0.15
- Stochastic Oscillator
- BEATW 0.00
- GMAB 13.13
About BEATW Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.